Details zur Studie XRAY VISION

Kurzname

Text

A randomized, double-blind, placebo-controlled, 2-arm Phase III study to assess efficacy and safety of xevinapant and radiotherapy compared to placebo and radiotherapy for demonstrating improvement of disease-free survival in participants with resected squamous cell carcinoma of the head and neck, who are at high-risk for relapse and are ineligible for high-dose cisplatin.

Diagnosegruppen

Linie

Phase

Fachbereich

Strahlentherapie

Haupt-Ansprechpartner:in

Telefon

Prüfer:in